医学
前列腺切除术
生化复发
前列腺癌
放射治疗
危险分层
队列
低风险
泌尿科
淋巴结
内科学
回顾性队列研究
挽救疗法
多元分析
肿瘤科
癌症
化疗
置信区间
作者
Sophia Scharl,Constantinos Zamboglou,Iosif Strouthos,Andrea Farolfi,Francesca Serani,Stefan A. Koerber,Jürgen Debus,Jan C. Peeken,Marco M. E. Vogel,Stephanie Kroeze,Matthias Gückenberger,Manuel Krafcsik,George Hruby,Louise Emmett,Nina-Sophie Schmidt-Hegemann,Christian Trapp,Simon K. B. Spohn,Christoph Henkenberens,Benjamin Mayer,Mohamed Shelan
标识
DOI:10.1016/j.radonc.2024.110215
摘要
The European Association of Urology (EAU) proposed a risk stratification (high vs. low risk) for patients with biochemical recurrence (BR) following radical prostatectomy (RP). Here we investigated whether this stratification accurately predicts outcome, particularly in patients staged with PSMA-PET.
科研通智能强力驱动
Strongly Powered by AbleSci AI